2011
DOI: 10.1155/2011/217564
|View full text |Cite
|
Sign up to set email alerts
|

Management and Outcome in 32 Neonates with Thrombotic Events

Abstract: Objective. To determine the incidence, management, complications, and outcome in neonates with thrombotic events. Study Design. We performed a retrospective study of all neonates with thrombotic events admitted to our neonatal intensive care unit from January 2004 to July 2010. Results. Thrombotic events were identified in 32 of 4734 neonates (0.7%). Seven neonates were managed expectantly and 25 neonates received anticoagulant treatment. Complete resolution of the clot within 3 months of age was found in 68% … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
1
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(37 citation statements)
references
References 20 publications
0
32
1
1
Order By: Relevance
“…It is mandatory to administer Low Molecular Weight Heparin (LMWH) as an anticoagulant to prevent thrombus propagation or embolism [13,14]. In the present case, LMWH was administered and significant improvement in the right upper limb was recorded.…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation
“…It is mandatory to administer Low Molecular Weight Heparin (LMWH) as an anticoagulant to prevent thrombus propagation or embolism [13,14]. In the present case, LMWH was administered and significant improvement in the right upper limb was recorded.…”
Section: Discussionmentioning
confidence: 75%
“…The infant in present study was administered low molecular weight heparin till discharge after one month. The infant was also given fresh frozen plasma to improve tissue perfusion and supply any deficient factor as it was recommended in few studies [1][2][3][10][11][12][13][14].…”
Section: Discussionmentioning
confidence: 99%
“…7,8 These differences shift the neonate into a somewhat prothrombotic state, which is balanced by other factors preventing spontaneous thromboses in well neonates. 9 However, numerous acquired and prothrombotic disorders may disrupt this balance, placing a neonate at risk for developing a clinically significant thrombosis ( Table 2).…”
Section: Neonatal Hemostasismentioning
confidence: 99%
“…Although a thrombotic event may present with obvious signs relating its location, the presence of an occult thrombosis should be considered where there is prolonged sepsis or there is persisting thrombocytopenia with no obvious other cause (van Elteren et al, 2011).…”
Section: The Therapeutic Optionsmentioning
confidence: 99%